Germline mutations in TP53 are associated with Li-Fraumeni syndrome, characterized by an increased risk of various cancers, including brain tumors, breast cancer, leukemia, sarcoma, adrenocortical carcinoma, and colon cancer (5). This evidence concerns the gene TP53 and cancer.